Zilia Launches Innovative Project to Detect a Rare Heart Disease
The study marks the first use of ocular spectroscopy to detect transthyretin (ATTR) amyloidosis, a rare but serious heart disease.
Zilia Receives ISO 13485:2016 Certification
Zilia has received certification from Intertek that its quality management system meets the ISO 13485 : 2016 standard for...
Impact of Vision Loss on Quality of Life
We experience the world using our five senses: sight, smell, taste, hearing, and touch. But which one is most important to our...
Ocular Oximetry: A Paradigm Shift in Retinal Vein Occlusion Management?
Retinal vein occlusion (RVO) affects more than 1.1 million people in the U.S. and is considered to be an important cause of...
Diabetic Retinopathy: A Key Role for Ocular Oximetry?
Diabetic retinopathy (DR), the most common complication of diabetes, is a retinal disease, characterized by ischemia,...
Zilia appoints Étienne Lagacé to its Board of Directors
Zilia is delighted to announce the appointment of Étienne Lagacé to its Board of Directors.For the last two decades, Étienne has...
Glaucoma Diagnosis and Management: What If We Could Intervene Sooner?
Glaucoma is a multifaceted ocular disease, which involves the degeneration of the optic nerve characterized by retinal ganglion...
Solutions